Separation and Functional Studies of the Human Lymphokine-Activated Killer Cell Kevan Roberts, Michael T
[CANCER RESEARCH 47, 4366-4371, August 15, 1987] Separation and Functional Studies of the Human Lymphokine-activated Killer Cell Kevan Roberts, Michael T. Lotze,1 and Steven A. Rosenberg Surgery Branch, National Cancer Institute, NÃŒH,Betnesda,Maryland 20892 ABSTRACT undefined. The purification of cells responsible for LAK activity was desirable to further assess their morphology, phenotype, Cell separation studies were undertaken in an attempt to purify the and target cell binding properties prior to and following IL-2 lymphokine-activated killer (LAK) precursor cell. Null cells, prepared stimulation. by the sequential depletion of monocytes, T- and B-lymphocytes from human peripheral blood mononuclear cells, were found to be potent mediators of LAK activity. Such preparations were Leu-11* but Leu-4" MATERIALS AND METHODS and displayed high levels of natural killer activity. Incubation of these cells with recombinant interleukin 2 (11-2) for periods in excess of 24 h Media. All cell lines were maintained in suspension culture using RPMI 1640 supplemented with 10% FBS, 100 ng/m\ penicillin, 100 induced LAK lysis of fresh tumor targets which were resistant to lysis Mg/ml streptomycin, and 1% glutamine. CM consisted of RPMI 1640 by unstimulated null effectors. In contrast, lymphocytes which formed high affinity rosettes with sheep RBC (I-* lymphocytes) were poor supplemented with 10% human AB serum, antibiotics, and glutamine. Conjugation buffer, at pH 7.3, was prepared by adding 683 mg of NaCl, mediators of both natural killer and LAK activity. Interleukin 2 stimu lated null cells, retained a Leu-ll*, I.t-u-4 phenotype, and expressed 142 mg of MgCl2 6H2O, and 66 mg of CaCl2-6H2O to 450 ml of PBS supplemented with 50 ml of FBS, antibiotics, and 10 HIM4-(2-hydrox- only low levels of receptors for II,-2 and transferrin.
[Show full text]